Roche Expects Sales, Earnings Growth After Better-Than-Expected Results
The company expects sales and core earnings to keep growing this year after beating analysts’ expectations for 2024, and the ...
Overview of common vision problems and medications
Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...
Why Opthea (OPT) Is Among the Best Australian Stocks to Buy Now?
We recently compiled a list of the 10 Best Australian Stocks to Buy Now. In this article, we are going to take a look at ...
Outlook Therapeutics’ ONS-5010 shown to be non-inferior to Lucentis in wet AMD
Outlook Therapeutics (OTLK) has completed the analysis of the complete 12-week safety and efficacy results for NORSE EIGHT, the second of two ...
Medscape24d
Alternative Anti-VEGF Treatment Regimens in Exudative Age-related Macular Degeneration
Bs: Bevasiranib sodium; CABERNET: A study of Strontium 90 β Radiation With Lucentis to Treat Age-Related Macular Degeneration; CARBON: Combination of Bevasiranib and Lucentis Therapy in Wet AMD ...
Associated Press28d
What is the Islamic State group and what attacks has it inspired?
Copyright 2025 The Associated Press. All Rights Reserved. The FBI now says that the pickup truck driver responsible for a deadly rampage in New Orleans acted alone ...